Company Filing History:
Years Active: 2007-2022
Title: Innovations of Qiaojuan Jane Su
Introduction
Qiaojuan Jane Su is a prominent inventor based in San Jose, California. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of 18 patents to her name, her work has had a substantial impact on medical research and therapeutic applications.
Latest Patents
One of her latest patents focuses on antibodies directed to the deletion mutants of the epidermal growth factor receptor (EGFR). This invention specifically targets the type III deletion mutant, known as EGFRvIII. The patent details human monoclonal antibodies that are directed against these deletion mutants, providing diagnostic and therapeutic formulations. The innovative nature of her work lies in the potential applications of these antibodies in treating various diseases.
Career Highlights
Throughout her career, Qiaojuan Jane Su has worked with notable companies such as Amgen Fremont Inc. and NextBio. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her coworkers include Jaspal Singh Kang and Orit Foord, who have also played significant roles in advancing research in biotechnology.
Conclusion
Qiaojuan Jane Su's contributions to the field of biotechnology through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in medical treatments and diagnostics.